Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study
<p>Abstract</p> <p>Background</p> <p>Acid suppression with a proton pump inhibitor is standard treatment for gastroesophageal reflux disease and erosive esophagitis in adults and increasingly is becoming first-line therapy for children aged 1-17 years. We evaluated endo...
Main Authors: | Youssef Nader N, Tolia Vasundhara, Gilger Mark A, Traxler Barry, Illueca Marta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | BMC Pediatrics |
Online Access: | http://www.biomedcentral.com/1471-2431/10/41 |
Similar Items
-
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
by: Gold Benjamin D, et al.
Published: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
by: Roy C Orlando, et al.
Published: (2010-09-01) -
Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: Focus on delayed-release esomeprazole
by: Elizabet V Guimar&atilde;es, et al.
Published: (2010-10-01) -
Genetic polymorphisms of CYP2C19 and IL1B have no influence on esomeprazole treatment for mild erosive esophagitis
by: Wen-Hung Hsu, et al.
Published: (2015-05-01) -
The Effect of Esomeprazole 40 mg Single Therapy in Patients with Non-Erosive Reflux Disease Who Are Resistant to Standard-Dose Proton Pump Inhibitor Therapy: An Open-Label Multicenter Study
by: Jae Kyu Sung, et al.
Published: (2016-12-01)